Tevogen (TVGN) Research & Development (2023 - 2026)
Tevogen's Research & Development was $3.13 million in Q1 2026, down 1.9% from $3.2 million a year earlier but up 48.9% from the prior quarter.
Powered by 
Analysis
Tevogen (TVGN) Research & Development (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, Tevogen's Research & Development was $11.05 million through Mar 31, 2026, down 17.6% year-over-year; for FY2025, it was $11.11 million, down 64.2% from FY2024.
- In earlier years, Research & Development was $31.03 million in FY2024 (+604.7%) and $4.4 million in FY2023.
- Quarterly Research & Development has moved between $908,049 (Q4 2023) and $20.81 million (Q1 2024) over five years.
- Compared with a year earlier, Research & Development has declined for five straight quarters, with growth averaging 69.1% over the last eight quarters.
- The best year-over-year quarter for Research & Development over five years was Q2 2024 (growth of 299.9%); the worst was Q1 2025 (a decline of 84.6%).
- Per Business Quant data, TVGN's Research & Development in the three quarters before Q1 2026 was $2.11 million (Q4 2025), $3.11 million (Q3 2025) and $2.7 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Tevogen | 24.97 Mn | 24.97 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 3.13 Mn |
| Dec 31, 2025 | 2.11 Mn |
| Sep 30, 2025 | 3.11 Mn |
| Jun 30, 2025 | 2.70 Mn |
| Mar 31, 2025 | 3.20 Mn |
| Dec 31, 2024 | 2.84 Mn |
| Sep 30, 2024 | 3.26 Mn |
| Jun 30, 2024 | 4.12 Mn |
| Mar 31, 2024 | 20.81 Mn |
| Dec 31, 2023 | 908,049.00 |
| Sep 30, 2023 | 1.12 Mn |
| Jun 30, 2023 | 1.03 Mn |
| Mar 31, 2023 | 1.35 Mn |
API Access
Tevogen Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=TVGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "TVGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=TVGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();